Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients worldwide.

We currently supply the following medicines in Ireland :

  • Advagraf® (tacrolimus monohydrate)
  • Betmiga™ (mirabegron)
  • Evrenzo® (Roxadustat)
  • Modigraf® (tacrolimus monohydrate)
  • Omnexel® (tamsulosin hydrochloride)
  • Prograf® (tacrolimus monohydrate)
  • Vesitirim™ (solifenacin succinate)
  • Vesomni™  (tamsulosin hydrochloride & soifenacin succinate)
  • Xtandi™ (enzalutamide)
  • PADCEV™ (enfortumab vedotin)
  • Veoza™ (fezolinetant)

Further information on the above products can be found at

MAT-IE-NON-2024-00019  - Date of Preparation April 2024.